S Henrich, R I Christopherson. Show Affiliations »
Abstract
Entities: Chemical Gene Species
Mesh: See more » Antimetabolites, Antineoplastic/pharmacologyApoptosis/drug effectsBurkitt Lymphoma/pathologyCell Line, Tumor/drug effectsCell Line, Tumor/metabolismDNA DamageDrug Resistance, Neoplasm/geneticsGenes, p53HumansIsoelectric PointLeukemia, Lymphocytic, Chronic, B-Cell/geneticsLeukemia, Lymphocytic, Chronic, B-Cell/pathologyMolecular WeightMutationNeoplasm Proteins/chemistryNeoplasm Proteins/drug effectsNeoplasm Proteins/geneticsPeptide Fragments/chemistryPeptide Fragments/metabolismPeptide Hydrolases/metabolismPhosphorylation/drug effectsProtein Processing, Post-Translational/drug effectsProtein Structure, TertiaryTumor Suppressor Protein p53/chemistryTumor Suppressor Protein p53/drug effectsVidarabine/analogs & derivativesVidarabine/pharmacology
Substances: See more » Antimetabolites, AntineoplasticNeoplasm ProteinsPeptide FragmentsTumor Suppressor Protein p53Peptide HydrolasesVidarabinefludarabine
Year: 2007 PMID: 17728781 DOI: 10.1038/sj.leu.2404929
Source DB: PubMed Journal: Leukemia ISSN: 0887-6924 Impact factor: 11.528